Detalles de la búsqueda
1.
A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial.
Gastric Cancer
; 25(4): 783-793, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35352176
2.
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer.
N Engl J Med
; 378(13): 1177-1188, 2018 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-29590544
3.
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials.
Lancet Oncol
; 21(12): 1620-1629, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33271092
4.
Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup Analysis.
Oncologist
; 25(6): e928-e935, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31943506
5.
Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer.
Haematologica
; 105(6): 1704-1711, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31558668
6.
Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
Oncologist
; 24(3): 385-393, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30606884
7.
Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease.
Lancet Oncol
; 19(3): e151-e160, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29508762
8.
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial.
Br J Cancer
; 117(8): 1099-1104, 2017 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28926529
9.
Assessment of a HER2 scoring system for colorectal cancer: results from a validation study.
Mod Pathol
; 28(11): 1481-91, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26449765
10.
Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: final results from an expanded-access trial.
Oncology
; 88(5): 273-80, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25592399
11.
Addressing the challenges of pancreatic cancer: future directions for improving outcomes.
Pancreatology
; 15(1): 8-18, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25547205
12.
MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma.
Liver Int
; 35(3): 1077-86, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25040368
13.
Time required to start multicentre clinical trials within the Italian Medicine Agency programme of support for independent research.
J Med Ethics
; 41(10): 799-803, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26066362
14.
Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial.
Lancet Oncol
; 14(10): 981-8, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23883922
15.
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials.
J Clin Oncol
; : JCO2301326, 2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38547438
16.
Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy.
Cancer
; 119(8): 1528-36, 2013 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23310947
17.
Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials.
J Clin Oncol
; 41(4): 803-815, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36306483
18.
Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohort.
J Thromb Haemost
; 21(7): 1869-1881, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37054917
19.
A New Risk Prediction Model for Venous Thromboembolism and Death in Ambulatory Lung Cancer Patients.
Cancers (Basel)
; 15(18)2023 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37760562
20.
Curative treatments for colon cancer during the COVID-19 pandemic era.
Tumori
; 108(4): 392-393, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34674577